Use of Multiple Specimen Types in RSV Testing May Improve Detection Rates, Suggests New Review and Meta-analysis
Adding paired serology and sputum to nasal swab/nasopharyngeal swabs RT-PCR increased RSV detection by 50% to 66% on average, respectively.
Daily Dose: Prevalence of Statin Use for ASCVD Prevention
Your daily dose of clinical news you may have missed.
AAFP President: We Need to Go Forward, Not Backward, on Racial Disparities in Health Care
Disparities in US health and health care delivery along some dimensions are moving backward, not forward, says AAFP president Iroku-Malize in this interview.
Best & Worst States for Physicians: 2023 Snapshot
Get a quick look at the 5 states ranking highest and lowest on metrics including wages, competition, state medical board punishment, cost of malpractice insurance, and size of malpractice payout.
Daily Dose: Statin-Eligible Minority Patients Sorely Undertreated
A daily dose of clinical news you may have missed.
FDA Proposed Rule Change Expands Use of Salt Substitutes to Lower NaCl Intake, Reduce Chronic Disease
The rule change would provide flexibility in standards that govern specific ingredients used in food production, permitting replacement of regular sodium with less toxic substitutes.
Friday's 5 Quotes for Primary Care: 3-24-2023
Statin-eligible patients in minority groups significantly undertreated; metabolically healthy obesity on the rise; menstruation irregularities suggest later CVD risk; and 2 more studies of note.
Dupilumab Achieves Outcomes in Phase 3 COPD Clinical Trial "Never Before Seen with a Biologic"
Dupilumab in patients with uncontrolled COPD reduced annual exacerbations by 30%, a statistically significant and clinically meaningful outcome and a first for a biologic.
3 Things Primary Care Should Remember About Sports Medicine
A sports medicine specialist talks about collaborating with primary care and says there are 3 things that help make the partnership work so well.
Obesity in the US: Highs and Lows by City
From highest percentage of adults with obesity to lowest percentage of adults with hypertension, see how obesity hits home in our new slideshow.
Rate of Statin Use for Primary ASCVD Prevention Substantially Lower in Black, Hispanic Persons
Analysis of NHANES data between 2013-2020 found statin use low across racial/ethnic groups and significantly lower among Black and Hispanic participants.
Candida auris: US Case Count Rising Rapidly
Drug-resistant cases of Candida auris continue to spread across the US after an alarming 95% rise in cases of the fungal infection in 2021.
AHA/ACC Release Scientific Statement on Benefits of Exercise Training in Persons with HFpEF
Studies on supervised exercise training in patients with chronic, stable HFpEF suggest substantial improvements in exercise capacity and QoL that may surpass those seen with medication.
Nonopioid Medications for Management of Acute Low Back Pain: What Works Best?
Which of the 3 nonopioid analgesics most commonly used to treat acute LBP is/are most effective? A new systematic literature review offers 1 view of the data.
Daily Dose: Menstrual Cycle Irregularities & Cardiometabolic Events in Later Life
Seen in the ED: Worsening Abdominal Pain, Distention in an Older Woman
Constipation, bloating, and abdominal pain worsening over 1 week bring a woman in her mid-70s to the ED. Labs are normal. What do you see on the CT scan?
Percentage of US Adults with Metabolically Healthy Obesity Increased in Past 2 Decades
Authors of new study say results underscore need for effective strategies to optimize metabolic status and prevent obesity-related complications among persons with obesity.
Menstrual Cycle Irregularities May Increase Risk for Cardiometabolic Events in Later Life
Women whose menstrual cycle varied in frequency had a significant 24% greater risk of a composite cardiovascular event during a 26-year follow-up, a new study reports.
Daily Dose: Antidepressant Discontinuation & Postpartum Psychiatric Outcomes
Sanofi Third Insulin Maker to Announce Price Reductions Across Brands
Sanofi is the third key insulin maker to announce reductions in the cost of its products, joining other giants Eli Lilly and Co and Novo Nordisk.
